• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

FDA updates Merck's Covid-19 pill EUA and reaffirms it should only be used as a last...

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Feb 18, 2022 at 10:52: AM
via The FDA recently revised the EUA for Merck’s Covid-19 pill molnupiravir, explaining that it should only be used as a last line of defense if other treatments are available, including Pfizer’s pill Paxlovid, which posted 89% final efficacy results in the NEJM this week. Regulators also said other more highly efficacious infused drugs, including GlaxoSmithKline’s sotrovimab and Gilead’s remdesivir, should be used before molnupiravir.

article source
 




Top Bottom
Back
Quote